Pancytopenia: Clinical Trials

4 trials for Pancytopenia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 22Completed 2

Follow Pancytopenia: new trials by email Literature Review of Pancytopenia trials Research Report on Pancytopenia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Cyclophosphamide, Cyclosporine - Aplastic Anemia, Neutropenia
Phase 1 / Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)222010-08-012017-05-22
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
Cyclophosphamide, Fludarabine - Aplastic Anemia, Neutropenia
Phase 1 / Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)12010-08-012021-07-02
Gene Therapy for the Treatment of Fanconi's Anemia Type C
Transduced CD34+ Cells - Fanconi's Anemia, Pancytopenia
Phase 1CompletedNational Heart, Lung, and Blood Institute (NHLBI)91993-12-032017-07-02
Stem Cell Factor Medication for Aplastic Anemia
Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) - Aplastic Anemia, Pancytopenia
Phase 1CompletedNational Heart, Lung, and Blood Institute (NHLBI)401993-10-012008-03-04

Narrower conditions

Anemia, Aplastic (3)  ·  Bone Marrow Failure Disorders (2)  ·  Neutropenia (2)  ·  Autoimmune Diseases (1)  ·  Fanconi Anemia (1)

Broader conditions

Anemia (4)  ·  Bone Marrow Diseases (4)  ·  Cytopenia (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Agranulocytosis (2)  ·  Bone Marrow Failure Disorders (2)  ·  Leukocyte Disorders (2)  ·  Leukopenia (2)  ·  Anemia, Aplastic (1)  ·  Anemia, Hypoplastic, Congenital (1)  ·  Congenital Bone Marrow Failure Syndromes (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  DNA Repair-Deficiency Disorders (1)  ·  Genetic Diseases, Inborn (1)

Interventions

Cyclophosphamide (2)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Influenza Vaccines (1)  ·  ancestim (1)  ·  fludarabine (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (4)

Countries

United States (4)

Top investigators

Danielle M Townsley, M.D. (2)

Results publications

PMID 25185712, PMID 34724566, PMID 37142543